Anticoagulation-associated hemorrhage in atrial fibrillation as a marker of occult malignancy: a narrative review
Open Access
- 13 October 2026
- journal article
- review article
- Published by Springer Nature in Thrombosis Journal
- Vol. 24 (1) , 93
Abstract
Atrial fibrillation (AF) is the most common arrhythmia in adults and significantly increases the risk of stroke. Due to common threats like systemic inflamKeywords
This publication has 47 references indexed in Scilit:
- Prediction model for major bleeding in anticoagulated patients with cancer-associated venous thromboembolism using machine learning and natural language processingClinical and Translational Oncology, 2024
- Impact of Newly Diagnosed Cancer on Bleeding Events in Patients with Atrial Fibrillation Treated with Direct Oral AnticoagulantsAmerican Journal of Cardiovascular Drugs, 2024
- Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare DatabaseCardiovascular Drugs and Therapy, 2024
- Anticoagulation and bleeding in the cancer patientSupportive Care in Cancer, 2022
- Retrospective Study of Bleeding Risk with Concomitant Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor and AnticoagulationThe Oncologist, 2021
- Screening for Colorectal CancerJAMA, 2021
- Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon CancerJAMA Oncology, 2019
- Screening for Prostate CancerJAMA, 2018
- Population-Based Colonoscopy Screening for Colorectal CancerJAMA Internal Medicine, 2016
- Pericytes on the Tumor Vasculature: Jekyll or Hyde?Cancer Microenvironment, 2012